HB6664: Innovation in Pediatric Drugs Act of 2023
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To encourage innovation in the development of pediatric drugs, and for other purposes.
Plain-language summary
The Innovation in Pediatric Drugs Act of 2023 aims to encourage pharmaceutical companies to develop new medicines specifically for children. The bill addresses the fact that many drugs are not tested or designed for pediatric use despite being prescribed to children. The sponsors include members from both parties focused on health policy. The bill was introduced in the House and is currently in the early stage of the legislative process.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB6664: Innovation in Pediatric Drugs Act of 2023
Upcoming hearings & events
Sponsors
Anna Eshoo
Primary SponsorCo-sponsors (9)
Michael McCaul
Darren Soto
Kim Schrier
Lori Trahan
Donald Davis